74723
1-Octadecanol
Selectophore™, ≥99.0%
Synonym(s):
Octadecyl alcohol, Stearyl alcohol
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
CH3(CH2)17OH
CAS Number:
Molecular Weight:
270.49
UNSPSC Code:
26111700
NACRES:
NA.05
PubChem Substance ID:
EC Number:
204-017-6
Beilstein/REAXYS Number:
1362907
MDL number:
Assay:
≥99.0% (GC), ≥99.0%
Form:
pellets
vapor density
9.3 (vs air)
Quality Level
vapor pressure
<0.01 mmHg ( 38 °C)
description
for ion-selective electrodes
product line
Selectophore™
assay
≥99.0% (GC), ≥99.0%
form
pellets
autoignition temp.
842 °F
expl. lim.
~8 %
mp
56-59 °C (lit.)
solubility
THF: 1 g/10 mL, clear, colorless
density
0.812 g/mL at 25 °C (lit.)
SMILES string
CCCCCCCCCCCCCCCCCCO
InChI
1S/C18H38O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19/h19H,2-18H2,1H3
InChI key
GLDOVTGHNKAZLK-UHFFFAOYSA-N
General description
Visit our Sensor Applications portal to learn more.
Legal Information
Selectophore is a trademark of Merck KGaA, Darmstadt, Germany
Still not finding the right product?
Explore all of our products under 1-Octadecanol
Storage Class
11 - Combustible Solids
wgk
nwg
flash_point_f
383.0 °F - closed cup
flash_point_c
195 °C - closed cup
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
M D Koone et al.
Archives of dermatology, 126(11), 1485-1490 (1990-11-01)
A number of inherited disorders of cornification have been related to abnormal lipid metabolism. In the recessively inherited Sjögren-Larsson syndrome, defined by the triad of ichthyosis, mental retardation, and spasticity, fatty alcohol:NAD+ oxidoreductase deficiency has recently been reported. These patients
Jin-Ki Kim et al.
ACS nano, 5(1), 209-216 (2010-12-17)
Nanocarrier systems are frequently characterized by their size distribution, while drug encapsulation in nanocarriers is generally characterized in terms of an entire population, assuming that drug distribution is uniform. Careful characterization of nanocarriers and assessment of their behavior in biological
Akhtar Siddiqui et al.
International journal of pharmaceutics, 431(1-2), 222-229 (2012-05-09)
The objective of this study was to increase the potency of doxorubicin against adriamycin-resistant NCI/ADR-RES cells by concurrent treatment with doxorubicin and MBO-asGCS loaded solid-lipid nanoparticles (SLN). Loading doxorubicin as ion-pair complex with deoxytaurocholate into cationic and neutral SLN was
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 1018505-200MG | 04061833839652 |
| A1260-100G | 04061833341988 |
| A1260-5G | 04061833342008 |
| PHR1711-500MG | 04061834801900 |
| 8200150010 | 04022536450353 |
| 8200150050 | 04022536450360 |
| A1260-25G | 04061833341995 |
| A0363000 | 04061833327814 |
| 74723-1G | 04061826651926 |
| 74723-5G | 04061833354711 |